Need more? Try out  Advanced Search (20+ criteria)»

Last Update

is this you? Claim your profile.

Wrong Martin Schlumberger?

Martin J. Schlumberger

Director, Nuclear Medicine and Endocrine Tumors Division

Institut Gustave Roussy

Email: m***@***.fr

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Institut Gustave Roussy

Villejuif, �le-de-France,

France

Find other employees at this company (593)

Background Information

Employment History

Medullary Specialist

Service de Médecine Nucléaire


Affiliations

Thyroid Cancer Alliance

Board Member


Education

M.D.


Web References(39 Total References)


Authors - Thyroid Disease ManagerThyroid Disease Manager

www.thyroidmanager.org [cached]

Martin Schlumberger , MD
Professor of Oncology, University of Paris-Sud, Director, Nuclear Medicine and Endocrine Tumors Division, Institut Gustave-Roussy, Villejuif, Paris, France.


Authors - Thyroid Disease ManagerThyroid Disease Manager

www.thyroidmanager.org [cached]

Martin Schlumberger , MD
Professor of Oncology, University of Paris-Sud, Director, Nuclear Medicine and Endocrine Tumors Division, Institut Gustave-Roussy, Villejuif, Paris, France.


World Congress on Thyroid Cancer » » Keynote Presentations

thyroidworldcongress.com [cached]

Prof. Martin Schlumberger, Institut Gustav-Roussy, Villjuif, France


www.pharmacy-life.co.uk

'Lenvatinib represents a paradigm shift in the treatment of advanced thyroid cancer, and will bring new options to patients and clinicians,' said Martin Schlumberger, primary investigator and Professor of Oncology at the Institut Gustave Roussy, University Paris Sud. 'Clinicians will be excited to prescribe a treatment with significant benefits in progression-free survival.'


www.cancernetwork.com

Results of EXAM were presented by Martin Schlumberger, MD, of Institut Gustave Roussy in Villejuif, France, and colleagues as a poster presentation at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting held May 29 to June 2 in Chicago.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory